查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球上游生物加工市场 2023-2030
市场调查报告书
商品编码
1380389

全球上游生物加工市场 2023-2030

Global Upstream Bioprocessing Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

全球上游生物加工市场预计在预测期内（2023-2030年）CAGR为11.1%。自动化上游生物加工优势的增加，例如改进的製程控制、提高的产品品质、减少的变异性、增加的产量和效率以及节省的成本，推动了市场的成长。越来越多地采用自动化上游生物加工和改进的软体是支持全球市场成长的关键因素。直接在生物生产实验室捕获资料可以帮助生物製程工程师提高製程理解，从而实现更稳健的製造流程并加快开发时间。各种上游生物反应器，用于自动化常规产品品质和细胞培养基分析。因此，市场参与者也专注于推出自动化上游生物加工解决方案，以进一步促进市场成长。例如，2023 年 9 月，沃特世公司推出了新的生物製程直接解决方案，旨在进一步简化生物样品的製备和分析。透过消除将生物反应器样本送到中央实验室进行分析的需要，新的解决方案使加速上游生物过程变得更加容易。 Waters OneLab (TM) 实验室自动化软体和新的预开发分析工作流程使生物製程工程师能够捕捉高品质的生物工艺

细分市场前景

全球上游生物加工市场按产品、工作流程和使用类型进行细分。根据产品，市场细分为生物反应器、细胞培养产品、过滤器、袋子和容器及其他（生物反应器配件）。根据工作流程，市场细分为培养基製备、细胞培养和细胞分离。此外，根据使用类型，市场分为多用途和单用途。在工作流程中，由于特定培养基配製的细胞培养物的开发不断增加，对哺乳动物细胞生长和实验结果产生显着影响，预计培养基製备细分市场将占据相当大的市场份额。培养基为细胞生长和调节细胞过程的化合物提供能量来源。

细胞培养产品细分市场预计将在全球上游生物加工市场中占据相当大的份额

其中，细胞培养产品细分市场预计将在全球上游生物加工市场中占据相当大的份额。分段生长归因于实验室中细胞系发育的影响越来越大，这些细胞系需要一种培养基来提供细胞培养物生存和增殖所需的营养。生长培养基还提供正确的渗透压和 pH 值。 CAR T 细胞的製造传统上依赖使用动物或人类血清，这些血清变化很大，并且可能含有外源性因子。血清需要严格的安全测试、筛选和储存品质合适的批次，导致生产过程更加昂贵和耗时。例如，2023 年 5 月，Lonza Group Ltd. 推出了 TheraPEAK (R) T-VIVO (R) 细胞培养基，这是一种为优化 CAR T 细胞製造而开发的新型化学成分确定的培养基。此培养基不含动物源成分，可提高一致性和製程控制，并简化监管审批，加快上市时间。

区域展望

全球上游生物加工市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本） 、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，亚太地区预计将在全球市场中占据显着份额，因为技术日新月异，各公司不断努力改进产品，重点关注研发。主要市场参与者包括BioSpectrum, Inc.、Fujifilm Holdings Corp.、Hash Biotech Labs、Samsung Biologics 等。

北美地区全球上游生物加工市场预计将以显着的CAGR成长

在所有地区中，北美地区预计在预测期内将以相当大的CAGR成长。区域成长归因于主要生物製药公司的存在、新生物分子和单株抗体研发投资的增加、慢性病负担的增加以及发达的基础设施的存在是推动该地区市场成长的主要因素。此外，自动化生物反应器的开发推动了该地区的成长，以安全、经济高效且符合法规的方式生产临床应用细胞产品。

由于生物相似药/生物分子、单株抗体和微小治疗胜肽生产研究的增加，该地区上游生物加工市场加速发展。对製程改进和清洁、安全、有效的生物分子生产燃料的需求导致了市场的扩张。采用专利细胞系的公司可以在细胞培养过程中获得较高的成功率，并实现最小的监管风险和高效的商业生产。主要市场参与者包括 Corning Inc.、Patheon NV、PBS Biotech, Inc.、Thermo Fisher Scientific, Inc. 等。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Corning, Inc.
    • 概述
    • 财务分析
    • SWOT分析
  • Sartorius AG
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Thermo Fisher Scientific Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按产品分類的全球上游生物加工市场
    • 生物反应器
    • 细胞培养产品
    • 过滤器
    • 袋子和容器
    • 其他（生物反应器配件）
  • 按工作流程分類的全球上游生物加工市场
    • 媒体准备
    • 细胞培养
    • 细胞分离
  • 按用途类型分類的全球上游生物加工市场
    • 多用途
    • 一次使用

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • AGC Inc.
  • Applikon Biotechnology
  • Bio-Connect Inc.
  • BioProcess International
  • Boehringer Ingelheim GmbH
  • CellGenix GmbH
  • Cytiva LifeScience
  • Danaher Corp.
  • Eppendorf AG
  • Esco Pharma
  • Getinge AB
  • Infors HT
  • Lonza Group Ltd.
  • Merck KGaA
  • Pall Corp.
  • PBS Biotech, Inc.
  • VWR International, LLC
Product Code: OMR2027798

Title: Global Upstream Bioprocessing Market Size, Share & Trends Analysis Report by Product (Bioreactors, Cell Culture Products, Filters, Bags and Containers and Others), by Workflow (Media Preparation, Cell Culture and Cell Separation), and by Use Type (Multi-Use and Single-Use),Forecast Period (2023-2030).

The global upstream bioprocessing market is anticipated to grow at a CAGR of 11.1% during the Forecast Period (2023-2030). An increase in advantage of automated upstream bioprocessing such as improved process control, enhanced product quality, reduced variability, increased throughput and efficiency, and cost savings drive the growth of market. The growing adoption of automated upstream bioprocessing with improved software is the key factor supporting the growth of the market globally. Capturing data directly at the bio production laboratory can help bioprocess engineers improve process understanding, leading to more robust manufacturing processes and accelerated development timelines. Various upstream bioreactors to automate routine product quality and cell culture media analyses. Hence, the market players are also focusing on launching automated Upstream Bioprocessing solutions that further bolster the market growth. For instance, in September 2023, Waters Corp. launched new bioprocess walk-up solutions designed to further simplify biologic sample prep and analysis. By eliminating the need to send bioreactor samples to a central laboratory for analysis, the new solutions make it even easier to accelerate upstream bioprocess. Waters OneLab™ laboratory automation software and new pre-developed analytical workflow allow bioprocess engineers to capture high-quality bioprocess

Segmental Outlook

The global upstream bioprocessing market is segmented on the product, workflow, and use type. Based on the product, the market is sub-segmented into bioreactors, cell culture products, filters, bags and containers and others (bioreactors accessories). Based on the workflow, the market is sub-segmented into media preparation, cell culture and cell separation. Further, on the basis of use type, the market is sub-segmented into multi-use and single-use. Among the workflow, the media preparation sub-segment is anticipated to hold a considerable share of the market owing to the rise in the development of specific media-formulated cell cultures that significantly impact mammalian cell growth and experimental outcomes. Culture media provide a source of energy for cell growth and compounds that regulate cellular processes.

The Cell Culture Products Sub-Segment is Anticipated to Hold a Considerable Share of the Global Upstream Bioprocessing Market

Among the products, the cell culture products sub-segment is expected to hold a considerable share of the global upstream bioprocessing market. The segmental growth is attributed to the growing influence of the development of cell lines in the lab that require a medium that supplies the nutrients necessary for cell cultures to survive and proliferate. The growth media also provides the correct osmolality and pH. The manufacture of CAR T-cells has traditionally relied on the use of animal or human serum, that is highly variable and may contain adventitious agents. Serum requires stringent safety testing, screening, and stockpiling of suitable-quality batches, making for a more costly and time-consuming manufacturing process. For instance, in May 2023, Lonza Group Ltd. launched the TheraPEAK® T-VIVO® Cell Culture Medium, a novel chemically defined medium developed to optimize CAR T-cell manufacture. Free from animal-origin components, the medium improves consistency and process control and simplifies regulatory approval for faster time-to-market.

Regional Outlook

The global Upstream Bioprocessing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the rapid technological advancements and companies are constantly working towards the improvement of their products with a major focus on research and development. The key market players include BioSpectrum, Inc., Fujifilm Holdings Corp., Hash Biotech Labs, Samsung Biologics and others.

The North America Region is Expected to Grow at a Significant CAGR in the Global Upstream Bioprocessing Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the presence of major biopharmaceutical companies, increasing investment for research and development of new biomolecules & mAbs, increasing chronic disease burden, and the presence of developed infrastructure are major factors that drive the market growth in this region. Moreover, the development of automated bioreactors for safe, cost-effective, and regulatory-compliant manufacturing of cell-based products for clinical applications has driven the region's growth.

The market for upstream bioprocessing in the region is accelerated by an increase in research into the production of biosimilars/biomolecules, monoclonal antibodies, and tiny therapeutic peptides. The demand for process improvement and clean, secure, and effective biomolecule production fuels results in the market's expansion. Companies adopting patented cell lines result in a high success rate in the cell cultivation process and enable minimal regulatory risk and efficient commercial production. The key market player includes Corning Inc., Patheon N.V., PBS Biotech, Inc., Thermo Fisher Scientific, Inc. and others.

Market Players Outlook

The major companies serving the upstream bioprocessing market include: Corning, Inc., Eppendorf AG, Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2023, Culture Biosciences and Cytiva are collaborating to advance innovation in upstream bioprocessing by providing customers greater access to predictive and robust scale-up capabilities. Together, Cytiva and Culture Biosciences aims to bring to customers new bioprocess solutions that use digitization, in-silico approaches, and virtual monitoring and control of experiments.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global upstream bioprocessing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Corning, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
  • 3.3. Sartorius AG
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Thermo Fisher Scientific Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Upstream Bioprocessing Market by Product
    • 4.1.1. Bioreactors
    • 4.1.2. Cell Culture Products
    • 4.1.3. Filters
    • 4.1.4. Bags and Containers
    • 4.1.5. Others (Bioreactors Accessories)
  • 4.2. Global Upstream Bioprocessing Market by Workflow
    • 4.2.1. Media Preparation
    • 4.2.2. Cell Culture
    • 4.2.3. Cell Separation
  • 4.3. Global Upstream Bioprocessing Market by Use Type
    • 4.3.1. Multi-Use
    • 4.3.2. Single-Use

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. AGC Inc.
  • 6.2. Applikon Biotechnology
  • 6.3. Bio-Connect Inc.
  • 6.4. BioProcess International
  • 6.5. Boehringer Ingelheim GmbH
  • 6.6. CellGenix GmbH
  • 6.7. Cytiva LifeScience
  • 6.8. Danaher Corp.
  • 6.9. Eppendorf AG
  • 6.10. Esco Pharma
  • 6.11. Getinge AB
  • 6.12. Infors HT
  • 6.13. Lonza Group Ltd.
  • 6.14. Merck KGaA
  • 6.15. Pall Corp.
  • 6.16. PBS Biotech, Inc.
  • 6.17. VWR International, LLC

LIST OF TABLES

  • 1. GLOBAL UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL UPSTREAM BIOPROCESSING BIOREACTORS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL UPSTREAM BIOPROCESSING CELL CULTURE PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 4. GLOBAL UPSTREAM BIOPROCESSING FILTERS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 5. GLOBAL UPSTREAM BIOPROCESSING BAGS AND CONTAINERS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 6. GLOBAL UPSTREAM BIOPROCESSING OTHERS PRODUCT MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 7. GLOBAL UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY WORKFLOW, 2022-2030 ($ MILLION)
  • 8. GLOBAL UPSTREAM MEDIA PREPARATION BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 9. GLOBAL UPSTREAM CELL CULTURE BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 10. GLOBAL UPSTREAM CELL SEPARATION BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 11. GLOBAL UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY USE TYPE, 2022-2030 ($ MILLION)
  • 12. GLOBAL UPSTREAM BIOPROCESSING FOR MULTI-USE MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 13. GLOBAL UPSTREAM BIOPROCESSING FOR SINGLE-USE MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 14. GLOBAL UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY WORKFLOW, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY USE TYPE, 2022-2030 ($ MILLION)
  • 19. EUROPEAN UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. EUROPEAN UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 21. EUROPEAN UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY WORKFLOW, 2022-2030 ($ MILLION)
  • 22. EUROPEAN UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY USE TYPE, 2022-2030 ($ MILLION)
  • 23. ASIA- PACIFIC UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 24. ASIA- PACIFIC UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY WORKFLOW, 2022-2030 ($ MILLION)
  • 26. ASIA- PACIFIC UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY USE TYPE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY WORK FLOW, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD UPSTREAM BIOPROCESSING MARKET RESEARCH AND ANALYSIS BY USE TYPE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL UPSTREAM BIOPROCESSING MARKET SHAREBY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL UPSTREAM BIOPROCESSING BIOREACTORS MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL UPSTREAM BIOPROCESSING CELL CULTURE PRODUCTS MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL UPSTREAM BIOPROCESSING FILTERS MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL UPSTREAM BIOPROCESSING BAGS AND CONTAINERS MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL UPSTREAM BIOPROCESSING OTHERS PRODUCT MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL UPSTREAM BIOPROCESSING MARKET SHAREBY WORKFLOW, 2022 VS 2030 (%)
  • 8. GLOBAL UPSTREAM MEDIA PREPARATION BIOPROCESSING MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL UPSTREAM CELL CULTURE BIOPROCESSING MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL UPSTREAM CELL SEPARATION BIOPROCESSING MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL UPSTREAM BIOPROCESSING MARKET SHAREBY USE TYPE, 2022 VS 2030 (%)
  • 12. GLOBAL UPSTREAM BIOPROCESSING FOR MULTI-USE MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL UPSTREAM BIOPROCESSING FOR SINGLE-USE MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL UPSTREAM BIOPROCESSING MARKET SHAREBY REGION, 2022 VS 2030 (%)
  • 15. US UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. UK UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF EUROPE UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD UPSTREAM BIOPROCESSING MARKET SIZE, 2022-2030 ($ MILLION)